Water for injection presentation

Making Pharmaceuticals - 24th & 25th April, Ricoh Arena, Coventry

This year at Making Pharmaeuticals, our Business Development Manager, James Steptoe is delivering a presentation, 'Water for injection production with a Reverse Osmosis-based system' on Tuesday 24th April at 16:55, in Room C.

We're also exhibiting so if you want to find out exactly how we can help your organisation, you can pre-book an appointment to speak to one of our experts on our stand on either of the two days, or come and visit us as you pass by.

Traditional distillation versus alternative purification processes

With recent regulatory changes made by the European Pharmacopoeia Monograph, there are some key questions being asked in the industry on how best practice and business processes may need to be adjusted. Our blog covers the key topics facing the water for injection (WFI) market including why the sudden change, what options are available and whether to use hot or cold water for WFI production.

Webinar - 6th June 2018, 10am - 11am

Our webinar discusses and explores the recent changes to the European Pharmacopoeia Monograph and the resulting impact on the Pharmaceutical market, in particular, water for injection. We take a look at the options now available to organisations producing WFI in terms of techniques, and consider the benefits of changing methods after the amends made to European regulations.

Please let us know your preferred date and time, along with any further information regarding your area of interest and we'll be happy to catch up with you at the event.

Please complete all fields
At Veolia Water Technologies we have exciting offers and news about our products and services that we hope you'd like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find details in our privacy policy.
Don't forget, you can always change your contact preferences at anytime by using the unsubscribe links you will find on all of our emails.